Stoke Therapeutics, Inc. ( STOK) - Stock Earnings
STOK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -38.3 million USD | 10.6 million USD |
| 2025Q4 | -57.9 million USD | 1.4 million USD |
| 2026Q1 | -50.0 million USD | 6.2 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
STOK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -104.7 million USD | 8.8 million USD |
| 2024 | -89.0 million USD | 36.6 million USD |
| 2025 | -6.9 million USD | 184.4 million USD |
| 2026 Est. | — | — |
STOK
Price: $30
52 week price:
Earnings Per Share: -2.86 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 66686
Market Capitalization: 1.8 billion